V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
[1] Decara JM, et al. J Med Chem. 2022 Apr 14;65(7):5449-5461.
V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
[1] Decara JM, et al. J Med Chem. 2022 Apr 14;65(7):5449-5461.